CTNND1 and breast carcinoma: Interestingly, in human breast cancer loss of p120 is mainly observed in focal areas within the tumour22, 47, suggesting that loss of p120 expression is a late event in tumour progression and is preceded by a first hit (for example, inactivation of p53).